2BB score and signals
Enanta Pharmaceuticals, Inc.’s current 2BB score is 39 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 43 | Moderate |
| Momentum | 96 | Strongly Improving |
| Financial strength | 7 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 46 | Moderate |
Company facts
| Headquarters | Watertown, Massachusetts, United States |
| Founded | 1995 |
| Employees | 120 |
| 52-week range | $6.60 – $17.15 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-08 | — | -0.4896 | — | $14.79M |
| 2026-11-16 | — | -0.799 | — | $14.48M |
| 2026-08-10 | -0.67 | -0.5202 | $14.36M | $17.13M |
| 2026-05-11 | -0.45 | -0.4978 | $17.16M | $17.43M |
Related companies
2BBBullish & Bearish